Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Negrier

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Expert Opinion on Biological Therapy|May 5, 2007
Haemophilia therapiesYesim Dargaud, Claude Negrier
Blood Advances|October 25, 2018
Emicizumab should be prescribed independent of immune tolerance inductionSandra Le Quellec, Claude Negrier
Lancet (London, England)|August 7, 2007
Coagulation factor concentrates: past, present, and futureNigel S Key, Claude Negrier
Thrombosis Research|September 27, 2008
Intraindividual thrombin generation measurement variability in healthy adults over a one year periodYesim Dargaud, Stephanie Francillon, Claude Negrier
Blood Reviews|June 6, 2019
The central role of thrombin in bleeding disordersClaude Negrier, Midori Shima, Maureane Hoffman
Blood|September 3, 2010
Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgeryYesim Dargaud, Anne Lienhart, Claude Negrier
Seminars in Hematology|July 17, 2008
Use of the thrombin generation test to evaluate response to treatment with recombinant activated factor VIIYesim Dargaud, Jean-Claude Bordet, Anne Lienhart, et al.
Thrombosis and Haemostasis|July 22, 2016
Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response. A review of the literatureSandra Le Quellec, Jean-Claude Bordet, Claude Negrier, et al.
Blood|May 11, 2011
Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia BClaude Negrier, Karin Knobe, Andreas Tiede, et al.
Annales De Biologie Clinique|September 28, 2010
[Assessment of the interest of using confirmatory test in ELISA with use of high concentration of heparin-induced thrombocytopenia]Karima Rissoul, Mouhcine Madani, Christophe Nougier, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Expert Opinion on Biological Therapy|May 5, 2007
Haemophilia therapiesYesim Dargaud, Claude Negrier
Blood Advances|October 25, 2018
Emicizumab should be prescribed independent of immune tolerance inductionSandra Le Quellec, Claude Negrier
Lancet (London, England)|August 7, 2007
Coagulation factor concentrates: past, present, and futureNigel S Key, Claude Negrier
Thrombosis Research|September 27, 2008
Intraindividual thrombin generation measurement variability in healthy adults over a one year periodYesim Dargaud, Stephanie Francillon, Claude Negrier
Blood Reviews|June 6, 2019
The central role of thrombin in bleeding disordersClaude Negrier, Midori Shima, Maureane Hoffman
Blood|September 3, 2010
Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgeryYesim Dargaud, Anne Lienhart, Claude Negrier
Seminars in Hematology|July 17, 2008
Use of the thrombin generation test to evaluate response to treatment with recombinant activated factor VIIYesim Dargaud, Jean-Claude Bordet, Anne Lienhart, et al.
Thrombosis and Haemostasis|July 22, 2016
Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response. A review of the literatureSandra Le Quellec, Jean-Claude Bordet, Claude Negrier, et al.
Blood|May 11, 2011
Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia BClaude Negrier, Karin Knobe, Andreas Tiede, et al.
Annales De Biologie Clinique|September 28, 2010
[Assessment of the interest of using confirmatory test in ELISA with use of high concentration of heparin-induced thrombocytopenia]Karima Rissoul, Mouhcine Madani, Christophe Nougier, et al.
Pageof 7